S1PR2 and rheumatoid arthritis: While additional research is needed, blocking S1P2 may lead to the inhibition of Th1 and Th17 cell differentiation; a decrease in Th1, Th17, and Treg cell populations; reduced expression of pro-inflammatory cytokines; and alleviation of RA symptoms.